Australia markets open in 4 hours 57 minutes

Cambium Bio Limited (CMB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0070+0.0010 (+16.67%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
-
-
-
7,956
1,663
Gross profit
-
-
-
7,956
1,663
Operating expenses
Research development
104.248
473.415
1,845
1,296
1,238
Selling general and administrative
-
1,075
2,780
4,230
3,702
Total operating expenses
1,496
2,318
4,650
5,580
5,014
Operating income or loss
-1,496
-2,318
-4,650
2,376
-3,351
Interest expense
412.725
350.202
72.656
75.039
271.471
Total other income/expenses net
1,543
981.66
413.041
-201.837
2,478
Income before tax
-366.011
-1,687
-4,310
2,153
-1,069
Income tax expense
0
0
0
0
0
Income from continuing operations
-366.011
-1,687
-4,310
2,153
-1,069
Net income
-366.011
-1,687
-4,310
2,153
-1,069
Net income available to common shareholders
-366.011
-1,687
-4,310
2,153
-1,069
Basic EPS
-0.01
-0.01
-0.01
0.01
-0.00
Diluted EPS
-0.01
-0.01
-0.01
0.01
-0.00
Basic average shares
306,430
306,437
305,603
303,538
265,884
Diluted average shares
306,430
306,437
305,603
303,538
265,884